Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition

ASX investors are bidding up the healthcare share amid ongoing growth.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is marching higher today.

Shares in the residential aged care provider closed yesterday trading for $5.83. In morning trade on Friday, shares are trading for $5.97 apiece, up 2.4%.

For some context, the ASX 300 is up 0.5% at this same time.

Created with Highcharts 11.4.3Regis Healthcare PriceZoom1M3M6MYTD1Y5Y10YALL1 Sep 20233 Jul 2025Zoom ▾Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Jan '24Jan '24Jul '24Jul '24Jan '25Jan '25www.fool.com.au

As you can see on the chart above, the Regis Healthcare share price is now up 123.6% over the past 12 months. And that doesn't even factor in the two partly franked dividends the company paid out over the year.

Here's what's moving the ASX 300 healthcare stock today.

ASX 300 healthcare stock expands residential aged care footprint

The Regis Healthcare share price is on the rise after the company announced it has entered into binding agreements to acquire two residential aged care homes from Ti Tree Operations.

The ASX 300 healthcare share will pay a net consideration of $35.5 million to the privately-owned residential aged care provider for the new assets.

The residential aged care homes are located in Capel Sound and Mornington in Victoria. They provide a combined 262 beds under the Village Glen trading name.

According to the release, both fully accredited homes had an average occupancy of 96% in Q4 FY 2024.

Commenting on the expansion that looks to be boosting the ASX 300 healthcare share today, Regis CEO Linda Mellors said, "We are excited to add these quality homes to our portfolio and broaden our footprint in Melbourne."

Mellors continued, "We look forward to welcoming the residents, families, employees and communities to Regis and ensuring a seamless transition of services."

Village Glen managing director Chas Jacobsen added:

We are delighted that Regis will be the new owner and custodian of the Capel Sound and Mornington facilities. We look forward to an ongoing and productive relationship between the parties into the future via our co-located retirement village.

The transaction remains subject to the customary regulatory approvals and conditions.

Regis expects the acquisition to settle on 2 December this year. It will be funded by the company's existing cash.

Once the acquisition is complete, and post the September closure of its Weston home in Western Australia, the ASX 300 healthcare share's aged care portfolio will expand to 68 homes with approximately 7,660 beds.

Atop that, Regis' new 112-bed residential aged care home in Camberwell, Victoria is scheduled to open by late 2024.

Regis comments on healthcare reforms

Separately, the ASX 300 healthcare share also applauded the government's bipartisan historic funding reforms to improve Australia's aged care system.

Commenting on those reforms, Mellors said:

After many years of chronic underfunding with a significant portion of the sector operating at a loss, we are now expecting more predictable and sustainable funding to invest in high-quality services and aged care homes that Australians expect…

As a result, Regis will now commence three greenfield developments in FY 2025, which will add 323 high quality beds to the portfolio.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Here are the latest growth forecasts for the CSL share price

Can this biotech giant deliver healthy returns?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

UP 127% in a year, why is the Pro Medicus share price rocketing higher again today?

ASX investors are sending Pro Medicus shares flying higher on Thursday. But why?

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Healthcare Shares

These healthcare stocks could be set to double according to broker

Interested in gaining exposure to the healthcare sector? These options could be ones to watch. 

Read more »

Shot of two young scientists using a laptop in a laboratory.
Healthcare Shares

Up 250% in a year, how much higher can this ASX healthcare share climb?  

The future looks promising for this biotech firm after delivering a record-quarterly result.

Read more »

shadow of a man looking out a window with arrows signifying falling share price
Healthcare Shares

Macquarie expects this ASX All Ords healthcare stock to fall 21% in FY26

The company faces several headwinds across multiple divisions.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Top broker names the best ASX healthcare shares to buy in FY26

Bell Potter has good things to say about these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Which ASX All Ords stock is jumping on record quarter?

This stock reported record sales during the past three months.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 36% in a year, why this $8 billion ASX 200 stock has still a 'strong growth forecast'

If you haven’t heard of this fast-rising ASX 200 stock yet, that’s about to change.

Read more »